Coronary Artery Disease and Polymorphisms in a Receptor Mediating Shear Stress–Dependent Platelet Activation
- 18 November 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (10) , 3281-3286
- https://doi.org/10.1161/01.cir.96.10.3281
Abstract
Background Platelets play pivotal roles in coronary thrombosis, and antiplatelet therapies are widely used for coronary artery disease (CAD). However, the effects of genetic variation in platelets on CAD are poorly understood. We have assessed the association between CAD and polymorphisms in a platelet receptor for von Willebrand factor, the glycoprotein (GP) Ib/IX complex, which mediates shear stress–dependent platelet activation. Methods and Results Genotypes of the α-chain of the receptor (GP Ibα, 145 Thr/Met) were determined in 91 patients with myocardial infarction (MI) or angina pectoris whose lesions were confirmed by coronary angiography as well as in 105 individuals from the general population with no history of angina or other heart diseases and normal resting ECGs. There was no homozygote for Met/Met in either the control or patient groups. The prevalence of the Thr/Met genotype (T/M) in all patients was not significantly different from that in the control group. However, the frequency of T/M was significantly higher in patients aged ≤60 years (31.8%) than in control subjects aged ≤60 years (16.0%; P <.05, odds ratio=2.5). An association was also demonstrated between CAD and the other polymorphism of GP Ibα, a variable number of tandem repeats of a 13–amino acid sequence, which is known to be linked to the 145 Thr/Met polymorphism. There was an association between the frequency of the T/M genotype and the angiographic severity of CAD: 11.1% for Gensini score P =.0015). There was no difference in the distribution of GP Ibα genotypes between patients with MI and those with angina pectoris. Conclusions This study suggests that the presence of the Met allele in GP Ibα is a risk factor for the prevalence and severity of CAD in individuals aged ≤60 years. The results need to be confirmed in a large-scale study of incident case subjects and matching control subjects.Keywords
This publication has 23 references indexed in Scilit:
- Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation‐based typingTransfusion, 1996
- NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens.Journal of Clinical Investigation, 1992
- The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplastyJournal of the American College of Cardiology, 1991
- The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.Journal of Clinical Investigation, 1991
- Platelet Hyperreactivity and Prognosis in Survivors of Myocardial InfarctionNew England Journal of Medicine, 1990
- Structure of the human blood platelet membrane glycoprotein Ibα geneBiochemical and Biophysical Research Communications, 1988
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Coronary Angioscopy in Patients with Unstable Angina PectorisNew England Journal of Medicine, 1986
- Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectorisThe American Journal of Cardiology, 1983
- A more meaningful scoring system for determining the severity of coronary heart diseaseThe American Journal of Cardiology, 1983